CNN

Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor ...

SHANGHAI, China and ST. HELIER, Jersey, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, and Novocure ...
Business Wire

Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating ...

SHANGHAI & CAMBRIDGE, Mass. & BAAR, Switzerland--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) and Novocure (NASDAQ: NVCR) announced that results from the Phase 3 PANOVA-3 trial of Tumor ...
Seeking Alpha

Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC ...

- Zai Lab (ZLAB) will highlight potential of ZL-1310 as a promising, best-in-class Delta-like ligand (DLL3-targeted) ADC for patients with extensive-stage small cell lung cancer (ES-SCLC) - Investor ...
来自MSN

A*STAR launches Smart Manufacturing Joint Lab phase two

It will focus on advanced technologies for aftermarket services, amongst others. The Agency for Science, Technology and Research (A*STAR), Rolls-Royce, and Singapore Aero Engine Services Private ...